Newfound Research’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$78K Sell
804
-100
-11% -$10.7K 0.19% 54
2022
Q2
$98K Sell
904
-291
-24% -$33K 0.21% 35
2022
Q1
$141K Buy
1,195
+54
+5% +$6.69K 0.18% 50
2021
Q4
$161K Buy
1,141
+167
+17% +$21.4K 0.19% 22
2021
Q3
$115K Buy
974
+238
+32% +$29.2K 0.19% 28
2021
Q2
$85K Buy
736
+71
+11% +$8.28K 0.17% 66
2021
Q1
$80K Sell
665
-425
-39% -$50.4K 0.19% 39
2020
Q4
$119K Buy
+1,090
New +$118K 0.31% 57

Other funds holding ABT

Newfound Research's ABT Position: Q3 2022 in Review

Newfound Research reduced its Abbott (ABT) stake by 11% in Q3 2022, selling an estimated $10.7K and leaving 804 shares worth $78K. The position accounts for 0.19% of the portfolio, ranked #54.

Newfound Research first reported a position in ABT in Q4 2020 and has held it in 8 quarters since. The position peaked at $161K in Q4 2021. 2,620 funds tracked by Wall St. Rank hold ABT as of Q3 2022.

  • Newfound Research held 804 shares of Abbott worth $78K as of Q3 2022.
  • Newfound Research sold 100 Abbott shares in Q3 2022, an estimated $10.7K.
  • Abbott made up 0.19% of Newfound Research's portfolio in Q3 2022, its #54 holding.
  • Newfound Research first reported a position in Abbott in Q4 2020 and has held it in 8 quarters since.
  • Newfound Research's Abbott position peaked at $161K in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Abbott as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.